Search Results 1271-1280 of 19365 for hemoglobin

1. A Phase I, Multi-Center, Open Label, Dose De-escalation and Expansion Study of Gemcitabine and Cisplatin with AG120 or Pemigatinib for Advanced Cholangiocarcinoma - Mayo Clinic

   Hemoglobin ≥ 8 g/dL (obtained ≤ 21 days prior to registration). Serum total bilirubin ≤ 2.0 x upper limit of normal (ULN), unless considered due to ...

2. A Study To Evaluate Intravenous Iloprost In Subjects With Symptomatic Raynaud's Phenomenon Secondary To Systemic Sclerosis - Mayo Clinic

   ... hemoglobin). Subjects with scleroderma renal crisis within 6 months of screening. Subjects with a concomitant life-threatening disease with a life ...

3. A Study to Assess the Effectiveness, Safety and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation - Mayo Clinic

   Hemoglobin < 10g /100 mL for male and < 9g/ 100 mL for female;; Platelets < 100 000/mm^3;; Creatinine ≥ 150 μmol/L. Patients on macrolide (e.g., azithromycin) ...

4. Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer - Mayo Clinic

   Hemoglobin ≥10 g/dL. WBC ≥4000/μL. ANC ≥2000/μL. Platelet count ≥100,000/μL. INR within institutional normal limits. aPTT within institutional normal ...

5. A Study of Levosimendan in Pulmonary Hypertension (PH) with Heart Failure (HF) and Preserved Left Ventricular Ejection Fraction (pEF) Patients - Mayo Clinic

   Hemoglobin < 80 g/L. Serum potassium < 3.0 mmol/L or > 5.5 mmol/L at baseline that is unresponsive to management . Participating Mayo Clinic locations. Study ...

6. Stereotactic Body Radiation Therapy in Treating Patients with Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable); If liver metastases ...

7. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable). Creatinine clearance (CrCL) ...

8. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL;; Absolute neutrophil count (ANC) ≥ 1000/mm^3;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase ...

9. Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; Bilirubin ≤ 1.5 times upper limit of normal (ULN); Creatinine ≤ 1.5 times ULN; No uncontrolled high blood pressure; No unstable angina ...

10. A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma or non-Hodgkin Lymphoma - Mayo Clinic

    Hemoglobin ≥ 7.5 g/dL (it is not permissible to transfuse a participant to reach this level). Inclusion Criteria - Part 2: With a confirmed diagnosis of ...